Loading...
Impact of specialty pharmacy taking ownership of the prior authorization process of multiple sclerosis specialty medications to increase access to infusible disease-modifying therapy (DMT)
Background: Multiple sclerosis (MS) is an autoimmune inflammatory demyelinating disease of the central nervous system (CNS) that is a leading cause of disability. Many disease-modifying therapies (DMT) with different routes of administration have been approved and introduced to the market to treat M...
Na minha lista:
| Udgivet i: | J Drug Assess |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6764359/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21556660.2019.1658304 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|